Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study
Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study
The need for and timing of booster doses of meningococcal vaccines in People Living with HIV
 (PLWHIV) is currently unknown. As such it is impossible for clinicians to recommend booster
 doses or to know if and when these might be necessary.We propose to follow up a group of
 participants from the Propositive study who received two doses of both MenB (Bexsero) and
 MenACWY (Menveo). This was a group of PLWHIV between the ages 18-45 years. We propose
 following up these participants at 12 and 24 months post completion of two doses of vaccine
 and investigating their immunological response.
Inclusion Criteria:

 -  Received vaccination with Bexsero and Menveo during Propositive study

 -  Able to sign fully informed consent

 -  Able to comply with study requirements

 Exclusion Criteria:

 • Unwilling or unable to comply with study requirements